| Andrew Aldeen Gordon, MD | |
|
835 S Wolcott Ave, E-144b, Chicago, IL 60612-3748 | |
| (312) 996-7420 | |
| Not Available |
| Full Name | Andrew Aldeen Gordon |
|---|---|
| Gender | Male |
| Speciality | Preventive Medicine - Occupational Medicine |
| Location | 835 S Wolcott Ave, Chicago, Illinois |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1902191539 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2083X0100X | Preventive Medicine - Occupational Medicine | 036.132171 (Illinois) | Primary |
| 2083X0100X | Preventive Medicine - Occupational Medicine | ME 122670 (Florida) | Secondary |
| Entity Name | American Current Care Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1770719296 PECOS PAC ID: 9739260019 Enrollment ID: O20090521000123 |
News Archive
The Takeda Oncology Company today announced the U.S. Food and Drug Administration (FDA) has accepted for review the Company's supplemental new drug application (sNDA) based on long- term overall survival (OS) data from the landmark VISTA1 trial examining the use of VELCADE based therapy in patients with previously untreated multiple myeloma (MM).
After 20 years of dedicated research, scientists have cracked the chemical code of an incredibly complex 'anti-tumor antibiotic' known to be highly effective against cancer cells as well as drug-resistant bacteria, and have reproduced it synthetically in the lab for the first time.
The final results of the Clinical Trial of COVID-19 Convalescent Plasma in Outpatients (C3PO) demonstrate that COVID-19 convalescent plasma did not prevent disease progression in a high-risk group of outpatients with COVID-19, when administered within the first week of their symptoms.
Extremely low dose CT coronary angiography can be used to measure cardiac function and has the potential for use when other commonly used examinations are limited, a preliminary study indicates.
A young woman who had been hospitalized for three months straight due to debilitating, recurrent infections with no apparent underlying cause was finally able to go home thanks to a Massachusetts General Hospital (MGH) team who put their heads together, discovered a root of the problem, and developed a novel treatment strategy just for her.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Andrew Aldeen Gordon, MD 739 S Claremont Ave, Apt. 1, Chicago, IL 60612-3516 Ph: (646) 209-3290 | Andrew Aldeen Gordon, MD 835 S Wolcott Ave, E-144b, Chicago, IL 60612-3748 Ph: (312) 996-7420 |
News Archive
The Takeda Oncology Company today announced the U.S. Food and Drug Administration (FDA) has accepted for review the Company's supplemental new drug application (sNDA) based on long- term overall survival (OS) data from the landmark VISTA1 trial examining the use of VELCADE based therapy in patients with previously untreated multiple myeloma (MM).
After 20 years of dedicated research, scientists have cracked the chemical code of an incredibly complex 'anti-tumor antibiotic' known to be highly effective against cancer cells as well as drug-resistant bacteria, and have reproduced it synthetically in the lab for the first time.
The final results of the Clinical Trial of COVID-19 Convalescent Plasma in Outpatients (C3PO) demonstrate that COVID-19 convalescent plasma did not prevent disease progression in a high-risk group of outpatients with COVID-19, when administered within the first week of their symptoms.
Extremely low dose CT coronary angiography can be used to measure cardiac function and has the potential for use when other commonly used examinations are limited, a preliminary study indicates.
A young woman who had been hospitalized for three months straight due to debilitating, recurrent infections with no apparent underlying cause was finally able to go home thanks to a Massachusetts General Hospital (MGH) team who put their heads together, discovered a root of the problem, and developed a novel treatment strategy just for her.
› Verified 7 days ago
Dr. Anne Judith Krantz, M.D. Preventive Medicine Medicare: Accepting Medicare Assignments Practice Location: 1901 W Harrison St, Chicago, IL 60612 Phone: 312-864-6000 | |
Michelle Theresa Watters, MD Preventive Medicine Medicare: Not Enrolled in Medicare Practice Location: 2121 W Taylor St, Sph/eohs, Occ. Med., Mc 684, Chicago, IL 60612 Phone: 312-413-0369 | |
Elijah Ezeofor, Preventive Medicine Medicare: Not Enrolled in Medicare Practice Location: 2133 W Lexington St, 2nd Floor Chicago Dept. Of Public Helath, Chicago, IL 60612 Phone: 312-746-4664 Fax: 312-746-6526 | |
Dr. Patrick Mccafferty Lank, M.D. Preventive Medicine Medicare: Medicare Enrolled Practice Location: 211 E Ontario St, Suite 200, Chicago, IL 60611 Phone: 312-926-6494 | |
Dr. Lourdes Mella Hilao, M.D. Preventive Medicine Medicare: Not Enrolled in Medicare Practice Location: 4243 W Fullerton Ave, Chicago, IL 60639 Phone: 773-489-5110 Fax: 773-489-5111 | |
Armando Salinas, Preventive Medicine Medicare: Not Enrolled in Medicare Practice Location: 2133 W Lexington St, Chicago, IL 60612 Phone: 312-746-5050 Fax: 312-746-6526 | |
Dr. Martin W Harrison, MD Preventive Medicine Medicare: Not Enrolled in Medicare Practice Location: 1318 W Catalpa Ave, Chicago, IL 60640 Phone: 312-972-6070 |